Biocontrol's CSO, Dr. David Harper today presented a plenary address to the Edinburgh International Phage Conference, entitled "Phage therapy: Raising the bar on the clinical work".

Featured in the Financial Times written by Jonathan Guthrie

http://www.ft.com/cms/s/0/53a92418-44ad-11dd-b151-0000779fd2ac.html

Featured in The Daily Express, written by Maisha Frost.

Scientists at Biocontrol Ltd have today presented at the Bacteriophage 2008 meeting in Hertfordshire a first look at the results of their initial Phase II clinical trial.

Scientists at Biocontrol, leading the world in developing new treatments to cure serious antibiotic-resistant infections, have secured a £250,000 investment from The Capital Fund.